surmount 1 tirzepatide lowers body weight for adults with obesity, regardless of disease duration Tirzepatide SURMOUNT-1 three year efficacy

Tirzepatide is an injectable drug that helps people lose weight by blocking fat absorption

Importantly, AOD9604 achieved these effects without activating the growth-promoting pathways that full-length growth hormone uses, which is why it doesnt cause the unwanted side effects of growth hormone therapy such as insulin resistance or abnormal growth

Most compounded Tirzepatide comes in 5mg, 10mg, or 15mg vials

patients per year, requiring only safety demonstration (not efficacy) with streamlined review and $6,375 in user fees

Compelling outcomes data that demonstrate the value of weight management will be critical for any expansion of access and reimbursement and change in clinical practice

due to "laziness", "greed", or a "lack of motivation"